References
- Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Paran D, et al. Vac-cination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNFec blockers. Ann Rheum Dis 2006;65:191–4.
- Kapetanovic MC, Saxne T, Nilsson JA, Pistoor F, Geborek P. Influ-enza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Ftheumatology 2007;46:608–11.
- Kaine J, Kivitz A, Birbara C, Luo AY. Abilities to develop protective antibodies to pneumococcal and influenza vaccine are maintained in rheumatoid arthritis patients treated with adalimumab (Humira). Arthritis Rheum 2006;54:S515–6.
- Herron A, Dettleff G, Hixon B, Brandwin L, Ortbals D, Hornick R, et al. Influenza vaccination in patients with rheumatic diseases: safety and efficacy. JAMA 1979;242:53–6.
- Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor a monoclonal antibody com-bined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552–63.